Back
ABVC BioPharma, Inc. 10K Form
Sell
16
ABVC
ABVC BioPharma, Inc.
Last Price:
$2.20
Seasonality Move:
-8.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ABVC News And Ratings
See the #1 stock for the next 7 days that we like better than ABVC
ABVC Financial Statistics
Sales & Book Value
| Annual Sales: | $509.6K |
|---|---|
| Cash Flow: | $-138.7K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.50 |
| Price / Book: | 4.11 |
Profitability
| EPS (TTM): | -0.22320 |
|---|---|
| Net Income (TTM): | $-4.4M |
| Gross Margin: | $307.9K |
| Return on Equity: | -54.57% |
| Return on Assets: | -29.85% |
ABVC BioPharma, Inc. Earnings Forecast
Key ABVC BioPharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 23 years for ABVC is 60.42%.
-
The Selling, General & Administrative Expenses for ABVC have been equal to 987.99% of Gross Profit Margin.
-
The Research & Development expenses have been 35.18% of Revenue.
-
The Net Earning history of ABVC is -1,031.99% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 12 years.
ABVC BioPharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ABVC |
| Website: | abvcpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.22 |
|---|---|
| Current Ratio: | 0.63 |
| Quick Ratio: | 0.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ABVC Technical Analysis vs Fundamental Analysis
Sell
16
ABVC BioPharma, Inc. (ABVC)
is a Sell
Is ABVC BioPharma, Inc. a Buy or a Sell?
-
ABVC BioPharma, Inc. stock is rated a SellThe current ABVC BioPharma, Inc. [ABVC] share price is $2.04. The Score for ABVC is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.